Trade Arcturus Therapeutics Holdings Inc - ARCT CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.06
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02237 %(-$0.45)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02237%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00015 %($0.00)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: 0.00015%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02237 %
  (-$0.45)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00015 %
  ($0.00)

Key Stats

• Prev. Close: 12.11
• Open: 11.69
• 1-Year Change: 24.63%
• Day's Range: 10.58 - 11.69

Trade Arcturus Therapeutics Holdings Inc - ARCT

What is Arcturus Therapeutics Holdings Inc (ARCT)?

Arcturus Therapeutics Holdings Inc is a biotechnology company focused on the development of RNA medicines. The company specializes in the design and manufacture of lipid nanoparticle delivery technology to enable the administration of RNA-based therapeutics and vaccines. Its research and development efforts encompass a range of therapeutic areas, including infectious diseases, rare diseases, and other medical conditions. Arcturus employs proprietary RNA chemistry and delivery platforms to create treatments that target specific genetic pathways. The company operates in the biopharmaceutical sector and collaborates with various partners to advance its pipeline of RNA medicines. Its scientific approach centers on leveraging messenger RNA (mRNA) technology to address unmet medical needs. The company’s activities include preclinical research, clinical trials, and manufacturing capabilities aimed at supporting the development and commercialization of RNA therapeutics. Arcturus Therapeutics Holdings Inc is part of the broader biotechnology industry that focuses on innovative medical solutions using genetic and molecular biology techniques.

Arcturus Therapeutics Holdings Inc Stock Price Today: Live Overview

The price today is shaped by live session movement, Arcturus Therapeutics Holdings Inc trades at $10.99. Its price has fluctuated between $10.56 and $11.78, with a daily change of -10.7084%.

FAQ: Arcturus Therapeutics Holdings Inc (ARCT)

What is the current price of ARCT stock?

Arcturus Therapeutics Holdings Inc is priced at $10.99 currently.

Does ARCT pay dividends?

Arcturus Therapeutics Holdings Inc does not pay dividends.

Does ARCT have a formal corporate presence or regional headquarters in the UAE?

Arcturus Therapeutics Holdings Inc operates in the UAE via partners and distributors without an official regional office or subsidiary.

What is ARCT best known for?

Arcturus Therapeutics Holdings Inc is most famous for its RNA medicines and vaccine technologies.

What assets are typically shown together with ARCT?

Commonly shown alongside ARCT: Nissan Motor Co., Ltd., SS&C Technologies Holdings Inc, Verbio